29
Jun 2026
Telehealth mindfulness program reduces chronic low back pain
Low back pain affects over 600 million people and is the single leading cause of disability worldwide.
Stay Informed!
29
Jun 2026
Anti-inflammatory molecule reduces excessive alcohol consumption in female mice
The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows that an anti-inflammatory molecule, already approved by the U.S. Food and Drug Administration to treat autoimmune diseases, reduces excessive alcohol consumption in alcohol-dependent female mice.
29
Jun 2026
Study links cardiovascular risk factors to visual impairment in Latinos
In the U.S., Hispanic/Latino populations are disproportionately at risk for eye diseases like glaucoma and diabetic retinopathy, or vision loss tied to diabetes.
29
Jun 2026
Scientists capture atomic images to improve RNA interference drug design
RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.
29
Jun 2026
New viral model triggers Parkinson's symptoms without using toxins
Scientists usually use animal models when studying Parkinson's disease because these models mimic the disease well.
29
Jun 2026
New drug candidate reduces toxic protein clumps of Huntington's disease
An experimental drug has been shown to alleviate symptoms of Huntington's disease and extend lifespan in mouse models. Further studies are required to determine whether these results may also apply to humans.
29
Jun 2026
Lung-on-a-chip tech reveals how asthma permanently alters airways
About 25 million people in the U.S. — roughly eight out of 100 — are diagnosed with asthma. Allergens, air pollution, extreme weather conditions, or other irritants can cause chronic lung inflammation, leading to coughing, wheezing, or shortness of breath.
29
Jun 2026
New schistosomiasis vaccine induces robust immune memory responses
For a vaccine to be effective, it must do two things. First, it must trigger an immune response. Second, the vaccine must train the body to remember the response so it can fight that same disease in the future.
29
Jun 2026
ARU secures funding to continue NHS Clinical Entrepreneur Programme
Anglia Ruskin University (ARU) has secured £4.8 million to continue delivering the NHS Clinical Entrepreneur Programme, which is playing an important role in supporting innovation across the National Health Service.
29
Jun 2026
Study reveals how leukemia cells invade lungs and cause breathing problems
Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue, and cause severe breathing problems.
